NOV 2.00% 5.1¢ novatti group limited

MSB drug application got rejected by the FDA and their SP...

  1. 659 Posts.
    lightbulb Created with Sketch. 65
    MSB drug application got rejected by the FDA and their SP dropped from $6 to 30c. It has shot back up last few weeks when insiders bought tens of millions of shares on market as MSB prepares to apply again by June 30. They now have a bunch of drugs that passed clinical trials and are lined up for FDA application.

    If NOV insiders started buying millions of shares, it would broadcast the same confidence.
 
watchlist Created with Sketch. Add NOV (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
0.001(2.00%)
Mkt cap ! $18.14M
Open High Low Value Volume
5.1¢ 5.1¢ 5.0¢ $4.178K 83.22K

Buyers (Bids)

No. Vol. Price($)
4 208698 5.0¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 21386 2
View Market Depth
Last trade - 15.44pm 20/05/2024 (20 minute delay) ?
Last
5.1¢
  Change
0.001 ( 2.00 %)
Open High Low Volume
5.1¢ 5.1¢ 5.1¢ 11121
Last updated 15.44pm 20/05/2024 ?
NOV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.